協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/07/23 | 1,811 | 1,831 | 1,802 | 1,821 | +2 | +0.1% | 832,600 |
2019/07/22 | 1,822 | 1,844 | 1,813 | 1,819 | -21 | -1.1% | 994,900 |
2019/07/19 | 1,824 | 1,845 | 1,818 | 1,840 | +19 | +1% | 1,118,600 |
2019/07/18 | 1,870 | 1,875 | 1,816 | 1,821 | -54 | -2.9% | 1,041,500 |
2019/07/17 | 1,879 | 1,890 | 1,867 | 1,875 | -10 | -0.5% | 914,100 |
2019/07/16 | 1,901 | 1,911 | 1,885 | 1,885 | -29 | -1.5% | 718,900 |
2019/07/12 | 1,921 | 1,927 | 1,903 | 1,914 | ±0 | ±0% | 782,100 |
2019/07/11 | 1,920 | 1,924 | 1,908 | 1,914 | +1 | +0.1% | 699,400 |
2019/07/10 | 1,905 | 1,918 | 1,900 | 1,913 | +14 | +0.7% | 1,114,100 |
2019/07/09 | 1,915 | 1,924 | 1,890 | 1,899 | +3 | +0.2% | 1,226,100 |
2019/07/08 | 1,900 | 1,902 | 1,885 | 1,896 | -28 | -1.5% | 1,345,100 |
2019/07/05 | 1,921 | 1,930 | 1,908 | 1,924 | +8 | +0.4% | 1,350,500 |
2019/07/04 | 1,928 | 1,937 | 1,914 | 1,916 | -9 | -0.5% | 1,313,500 |
2019/07/03 | 1,921 | 1,943 | 1,915 | 1,925 | -27 | -1.4% | 1,227,900 |
2019/07/02 | 1,961 | 1,977 | 1,951 | 1,952 | -10 | -0.5% | 985,000 |
2019/07/01 | 1,943 | 1,969 | 1,937 | 1,962 | +23 | +1.2% | 1,309,700 |
2019/06/28 | 1,916 | 1,955 | 1,912 | 1,939 | +11 | +0.6% | 1,553,900 |
2019/06/27 | 1,949 | 1,949 | 1,916 | 1,928 | -29 | -1.5% | 1,343,000 |
2019/06/26 | 1,950 | 1,972 | 1,934 | 1,957 | -15 | -0.8% | 943,600 |
2019/06/25 | 1,975 | 2,005 | 1,970 | 1,972 | -9 | -0.5% | 931,000 |
2019/06/24 | 1,984 | 1,991 | 1,971 | 1,981 | -3 | -0.2% | 693,200 |
2019/06/21 | 2,029 | 2,034 | 1,981 | 1,984 | -47 | -2.3% | 1,187,500 |
2019/06/20 | 2,047 | 2,067 | 2,030 | 2,031 | +5 | +0.2% | 717,500 |
2019/06/19 | 2,029 | 2,039 | 2,018 | 2,026 | +11 | +0.5% | 744,500 |
2019/06/18 | 2,046 | 2,051 | 2,004 | 2,015 | -12 | -0.6% | 713,700 |
2019/06/17 | 2,033 | 2,052 | 2,023 | 2,027 | -7 | -0.3% | 695,900 |
2019/06/14 | 2,022 | 2,047 | 2,004 | 2,034 | +33 | +1.6% | 1,860,900 |
2019/06/13 | 2,020 | 2,020 | 1,982 | 2,001 | -20 | -1% | 966,300 |
2019/06/12 | 2,038 | 2,040 | 2,021 | 2,021 | -37 | -1.8% | 802,300 |
2019/06/11 | 2,022 | 2,064 | 2,020 | 2,058 | +38 | +1.9% | 787,200 |
2019/06/10 | 2,043 | 2,043 | 2,014 | 2,020 | +9 | +0.4% | 833,800 |
2019/06/07 | 2,015 | 2,029 | 2,011 | 2,011 | -11 | -0.5% | 523,700 |
2019/06/06 | 2,007 | 2,047 | 2,000 | 2,022 | +13 | +0.6% | 680,100 |
2019/06/05 | 2,012 | 2,036 | 2,004 | 2,009 | +4 | +0.2% | 841,700 |
2019/06/04 | 2,020 | 2,027 | 2,001 | 2,005 | -10 | -0.5% | 914,600 |
2019/06/03 | 2,019 | 2,023 | 1,995 | 2,015 | -35 | -1.7% | 861,900 |
2019/05/31 | 2,064 | 2,090 | 2,049 | 2,050 | -24 | -1.2% | 881,400 |
2019/05/30 | 2,077 | 2,084 | 2,062 | 2,074 | -28 | -1.3% | 616,000 |
2019/05/29 | 2,099 | 2,111 | 2,071 | 2,102 | -32 | -1.5% | 853,900 |
2019/05/28 | 2,125 | 2,144 | 2,120 | 2,134 | +11 | +0.5% | 1,938,300 |
2019/05/27 | 2,106 | 2,135 | 2,106 | 2,123 | +30 | +1.4% | 990,600 |
2019/05/24 | 2,070 | 2,094 | 2,058 | 2,093 | +17 | +0.8% | 1,264,900 |
2019/05/23 | 2,106 | 2,118 | 2,074 | 2,076 | -15 | -0.7% | 1,466,800 |
2019/05/22 | 2,070 | 2,105 | 2,050 | 2,091 | +56 | +2.8% | 1,811,600 |
2019/05/21 | 2,043 | 2,061 | 2,033 | 2,035 | -8 | -0.4% | 935,700 |
2019/05/20 | 2,020 | 2,052 | 2,016 | 2,043 | +28 | +1.4% | 768,500 |
2019/05/17 | 2,008 | 2,036 | 2,005 | 2,015 | +19 | +1% | 944,500 |
2019/05/16 | 1,986 | 1,998 | 1,969 | 1,996 | +2 | +0.1% | 1,154,200 |
2019/05/15 | 1,983 | 2,004 | 1,967 | 1,994 | +10 | +0.5% | 1,278,800 |
2019/05/14 | 1,961 | 1,990 | 1,955 | 1,984 | -8 | -0.4% | 1,043,100 |
1301~
1350
件表示中 / 3581件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 257,000円 | +11.3% | -5.4% | 2.26% | 19.78倍 | 1.56倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 214,000円 | +5.7% | +3.9% | 2.68% | 10.65倍 | 1.41倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 502,900円 | +1.7% | -2.9% | 3.18% | 32.99倍 | 1.73倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 181,500円 | -3.5% | -50.2% | 4.41% | 14.70倍 | 1.09倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 274,400円 | +18.2% | +4.2% | 1.20% | 19.45倍 | 2.48倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム